Cooke & Bieler LP Sells 52,470 Shares of Varex Imaging Co. (NASDAQ:VREX)

Cooke & Bieler LP lessened its position in shares of Varex Imaging Co. (NASDAQ:VREXFree Report) by 2.2% in the second quarter, HoldingsChannel.com reports. The fund owned 2,326,443 shares of the company’s stock after selling 52,470 shares during the period. Cooke & Bieler LP owned about 0.06% of Varex Imaging worth $34,269,000 at the end of the most recent reporting period.

Other large investors have also made changes to their positions in the company. Pzena Investment Management LLC lifted its stake in Varex Imaging by 41.5% during the second quarter. Pzena Investment Management LLC now owns 2,569,213 shares of the company’s stock worth $37,845,000 after purchasing an additional 753,454 shares during the last quarter. Natixis Advisors LLC bought a new stake in shares of Varex Imaging during the 2nd quarter worth $210,000. Innealta Capital LLC acquired a new stake in Varex Imaging in the second quarter valued at about $26,000. Assenagon Asset Management S.A. grew its position in Varex Imaging by 27.7% in the second quarter. Assenagon Asset Management S.A. now owns 135,124 shares of the company’s stock valued at $1,990,000 after acquiring an additional 29,340 shares during the last quarter. Finally, Wedge Capital Management L L P NC lifted its holdings in shares of Varex Imaging by 3.9% in the second quarter. Wedge Capital Management L L P NC now owns 81,579 shares of the company’s stock worth $1,202,000 after acquiring an additional 3,068 shares during the last quarter.

Analysts Set New Price Targets

Separately, B. Riley assumed coverage on shares of Varex Imaging in a research note on Friday, August 23rd. They set a “buy” rating and a $21.00 target price on the stock.

Read Our Latest Research Report on VREX

Insider Buying and Selling

In other Varex Imaging news, CFO Shubham Maheshwari acquired 10,000 shares of the company’s stock in a transaction dated Monday, August 12th. The shares were bought at an average cost of $10.82 per share, with a total value of $108,200.00. Following the purchase, the chief financial officer now directly owns 56,063 shares of the company’s stock, valued at $606,601.66. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In related news, CFO Shubham Maheshwari bought 10,000 shares of the company’s stock in a transaction that occurred on Monday, August 12th. The shares were bought at an average price of $10.82 per share, for a total transaction of $108,200.00. Following the transaction, the chief financial officer now directly owns 56,063 shares of the company’s stock, valued at $606,601.66. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, SVP Kimberley E. Honeysett sold 2,578 shares of the firm’s stock in a transaction on Tuesday, August 20th. The stock was sold at an average price of $12.53, for a total transaction of $32,302.34. Following the completion of the sale, the senior vice president now owns 275 shares of the company’s stock, valued at $3,445.75. The disclosure for this sale can be found here. 5.20% of the stock is owned by insiders.

Varex Imaging Trading Down 0.4 %

Shares of NASDAQ:VREX traded down $0.05 during midday trading on Wednesday, hitting $11.80. 590,639 shares of the stock were exchanged, compared to its average volume of 405,776. Varex Imaging Co. has a 12 month low of $10.72 and a 12 month high of $21.50. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.89 and a current ratio of 3.34. The stock has a market capitalization of $482.62 million, a price-to-earnings ratio of 13.27 and a beta of 0.59. The business’s 50-day moving average price is $13.38 and its 200 day moving average price is $15.38.

Varex Imaging (NASDAQ:VREXGet Free Report) last announced its earnings results on Thursday, August 1st. The company reported $0.14 EPS for the quarter, missing the consensus estimate of $0.19 by ($0.05). The company had revenue of $209.00 million during the quarter, compared to the consensus estimate of $209.50 million. Varex Imaging had a net margin of 4.11% and a return on equity of 6.11%. The business’s revenue was down 10.0% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.37 earnings per share. Analysts predict that Varex Imaging Co. will post 0.46 earnings per share for the current year.

About Varex Imaging

(Free Report)

Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers.

Featured Articles

Want to see what other hedge funds are holding VREX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Varex Imaging Co. (NASDAQ:VREXFree Report).

Institutional Ownership by Quarter for Varex Imaging (NASDAQ:VREX)

Receive News & Ratings for Varex Imaging Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varex Imaging and related companies with MarketBeat.com's FREE daily email newsletter.